Drug recall · August 8, 2018
Indomethacin Capsules recall
Why: Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854; By: Hetero, Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India; NDC 31722-543-01.
- Lots / codes
Lot #: E180315, Exp 12/19
- Quantity
- 18,288 bottles
- Company
- Hetero Labs, Ltd. - Unit III, Hyderabad, N/A
- Distribution
- Nationwide in the USA
- Initiated
- July 18, 2018 · Voluntary: Firm initiated
- Classified
- July 27, 2018
- Reported
- August 8, 2018
- Ended
- July 15, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Indomethacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.